HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Cannata, J. B Articles by Junor, B. J.R. Search for Related Content PubMed Articles by Cannata, J. B Articles by Junor, B. J.R.

COMPARISON OF CONTROL OF SERUM PHOSPHATE LEVELS DURING CONTINUOUS AMBULATORY PERITONEAL DIALYSIS AND DURING HEMODIALYSIS

^* On attachment from the Hospital General de Asturias, Oviedo, Spain. ^** Renal Unit, Western Infirmary, Glasgow, Scotland. ^*** University Dept. of Pathological Biochemistry, Royal Infirmary, Glasgow, Scotland.

Recent reports have suggested that oral aluminium hydroxide carries the risk of aluminium toxicity. We have compared the aluminium hydroxide dose and serum levels of phosphate and aluminium in 27 CAPD and 26 hemodialysis patients. Despite a more liberal protein intake and lower aluminium hydroxide dose, the CAPD patients achieved the same serum phosphate level as those on hemodialysis. While the reason for more efficient serum phosphate control with CAPD is uncertain, the better control gives CAPD an advantage in patients in whom it is particularly important to minimise exposure to aluminium.

Copyright © 1983 by Multimed Inc.